Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026

Recent News Articles

November 9, 2015

Every month is marrow awareness month for Luis Lopez.

Lopez, who received the Awareness Award from the National Marrow Donor Program last week, has been an advocate for bone marrow donor registration since his daughter Lily was diagnosed with acute lymphoblastic leukemia in 2011.

He worked tirelessly to find a matching donor for his daughter, since a bone marrow transplant plays a critical role in the treatment of blood cancers. However, the one match generated from the Be The Match registry was unable to donate.

Lily died in 2014, but Luis’ efforts continue. He works closely with staff from the GenCure Marrow Donor Program on recruitment for the Be The Match registry, and he is serving as the keynote speaker at the GenCure Marrow Donor Program’s Donor Appreciation Dinner on Friday, Nov. 13.

October 26, 2015

One of the latest studies in the ever-growing field of stem-cell therapy will begin later this year at the University of Pittsburgh, as researchers look into regenerating the main blood vessel in the body.

Bioengineers at Pitt’s Swanson School of Engineering will be looking into ways to use stem cells to restore and regenerate the aorta. A weakening and enlargement of the aorta – known as an abdominal aortic aneurysm (AAA) – can rupture, causing life-threatening bleeding.

Ruptured abdominal aortic aneurysms are responsible for 10,000 deaths a year in the United States.

October 7, 2015

In recent years, the use of donated human tissue for a wide range of medical purposes has expanded dramatically.

One of the areas where skin tissue has used in increasing amounts is in breast reconstruction surgery following breast cancer surgery. Plastic surgeons are using what are known as acellular dermal matrices to help support and augment tissues, according to the American Cancer Society.

ADMs, as they are known, are derived from skin but have had cells removed that can cause rejection or transmit diseases. Working under guidelines of the American Association of Tissue Banks and the Food and Drug Administration, GenCure, a subsidiary of BioBridge Global, supplies skin tissue to companies that create ADMs.

Event to Raise Funding for Stem Cell Expansion Laboratory for BioBrodge Global Subsidiary GenCure
September 28, 2015

The Red and White Ball, the annual marquee event of The Blood & Tissue Center Foundation, is coming up on Saturday, Oct. 3.

Proceeds from the event will help GenCure establish a stem cell expansion laboratory. GenCure, The Foundation, QualTex Laboratories and the South Texas Blood & Tissue Center are subsidiaries of San Antonio-based BioBridge Global.

The GenCure laboratory is designed to widen the availability of stem cells, which are used as part of therapy for certain cancers. GenCure's stem cells come exclusively from donated umbilical cord blood and adult donors.

September 14, 2015

The U.S. House of Representatives has approved legislation to extend federal programs supporting research and therapy using bone marrow and cord blood.

The bill passed Tuesday authorizes $23 million annually for the National Cord Blood Inventory Program and $30 million per year for the C.W. Bill Young Cell Transportation Program through fiscal year 2020.

Co-sponsored by U.S. Reps. Chris Smith (R-N.J.) and Doris Matsui (D-Calf.), the Stem Cell Therapeutic and Research Reauthorization Act of 2015 continues programs that otherwise would have expired on Sept. 30. It passed on a voice vote after less than 10 minutes of debate.

The measure still must be approved by the Senate.